- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01525355
EUS Prior to ERCP in the Positive Setting of Positive Intraoperative Cholangiogram (IOC) During Cholecystectomy
A Prospective Study Evaluation the Role of EUS Prior to ERCP in the "Positive" Setting of Positive Intraoperative Cholangiogram (IOC) During Cholecystectomy
Study Overview
Status
Conditions
Detailed Description
During routine cholecystectomy, surgeons will often perform an intraoperative cholangiogram in an effort to define anatomical landmarks and ensure patency and drainage of the common bile duct. This involves injecting a radiopaque contrast medium into the biliary tree during the operation. Occasionally contrast injection onto the common bile duct will reveal an abnormality and are deemed a "positive intraoperative cholangiogram" (positive IOC). These abnormalities can include the following: single or multiple stones; non-filling of the duodenum by contrast; stenosis or narrowing of the common bile duct (CBD). When discovered these findings are better addressed and treated endoscopically via endoscopic retrograde cholangiopancreatography (ERCP). ERCP's are considered the gold standard for the diagnosis and treatment of positive intraoperative cholangiograms. However, several studies have shown that 40-50% of patients who undergo an ERCP after a "positive" IOC have a normal cholangiogram. Reasons for this include spontaneous stone passage of the stone, dysmotility of the biliary tree, or poor quality, incomplete, or misinterpretation of the IOC. Therefore ERCP's are being performed when they could be avoided. ERCP performance carries significant complications including pancreatitis (5-10%), bleeding, and perforation. Ideally if a safer test to assess the bile duct could be performed immediately prior to the ERCP to confirm the presence of the positive IOC findings, this would ensure that the ERCP is being performed for therapeutic means thus avoiding unnecessary ERCP's.
EUS is often performed prior to ERCP's under the same sedation in our endoscopy unit. From 2005 to 2007, two hundred and twenty seven "combined EUS and ERCP procedure were performed.(unpublished internal data). Our experience with "combined" EUS and ERCP procedures has demonstrated that performing an EUS prior to an ERCP will prolong the total procedure time less than 10 minutes with no significant increase in adverse events. Performance of an EUS prior to ERCP to confirm biliary pathology after a "positive" IOC has never been studied in a rigorous fashion.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subjects must be able to review and sign informed consent
- Cholecystectomy must have been performed within one month of enrollment
- Positive intraoperative cholangiogram
- Stone
- Multiple Stones
- Stenosis
- "non filling" of duodenum
- Dilated bile duct
Exclusion Criteria:
- Cannot give and sign informed consent
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
EUS prior to ERCP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bile Duct
Time Frame: 2 years
|
Stone seen by EUS confirmed by ERCP
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lesions
Time Frame: 2 Years
|
Presence of obstuctinn lesion seen by EUS
|
2 Years
|
|
Bile duct
Time Frame: 2 years
|
Diameter of common bile duct and common hepatic duct
|
2 years
|
|
Diverticulum
Time Frame: 2 years
|
Presence of periampullary diverticulum seen by endoscopy
|
2 years
|
|
ERCP
Time Frame: 2 years
|
Number of ERCP's that could have been avoided
|
2 years
|
|
ERCP
Time Frame: 2 years
|
Complications from ERCP
|
2 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: John A Evans, MD, Wake Forest University Baptist Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00013737
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Calculi
-
Seoul National University HospitalCompletedKidney Calculi; Ureteral CalculiKorea, Republic of
-
Amai Charitable TrustUnknown
-
Queen's UniversityUnknown
-
Assaf-Harofeh Medical CenterUnknownUreteral Calculi | Renal CalculiIsrael
-
Helwan UniversityRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
Indiana Kidney Stone InstituteCompleted
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
University of Sao Paulo General HospitalCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Unknown
-
Indiana Kidney Stone InstituteIndiana University School of MedicineCompletedRenal CalculiUnited States